If you want to provide feedback or any other inquiry on mimicINTweb or the mimicINT workflow, please, contact Andreas Zanzoni via the following contact form by putting “mimicINT” in the message subject:
https://tagc.univ-amu.fr/fr/contact/mimicintweb
People involved in the mimicINT(web) development:
Sébastien A. Choteau, Kevin Maldonado, Aurélie Bergon, Marceau Cristianini, Mégane Boujeant, Lilian Drets, Christine Brun, Lionel Spinelli, Andreas Zanzoni.
You can find a stand-alone version of the mimicINT workflow on GitHub:
https://github.com/TAGC-NetworkBiology/mimicINT
If you use mimicINT in your work, please cite our paper:
https://doi.org/10.1101/2022.11.04.515250
Halwachs B, Moesslacher CS, Kohlmayr JM, Fasching S, Masser S, Choteau SA, Zanzoni A, Kunowska N, Stelzl U. Modulation of human kinase activity through direct interaction with SARS-CoV-2 proteins. BioRxiv.
doi: https://doi.org/10.1101/2023.11.27.568816
Young V, Dohai B, Hitch TAC, Hyden P, Weller B, van Heusden NS, Saha D, Fernandez Macgregor J, Maseko SB, Lin CW, Boujeant M, Choteau SA, Ober F, Schwehn P, Rothballer S, Altmann M, Altmann S, Strobel A, Rothballer M, Tofaute M, Heinig M, Clavel T, Twizere JC, Vincentelli R, Boes M, Krappmann D, Falter C, Rattei T, Brun C, Zanzoni A, Falter-Braun P. A gut meta-interactome map reveals modulation of human immunity by microbiome effectors. BioRxiv.
doi: https://doi.org/10.1101/2023.09.25.559292
This work was supported by: the European Union’s Horizon 2020 Research and Innovation Programme [Project ID 101003633, RiPCoN, https://doi.org/10.3030/101003633];
the JPI HDHL-INTIMIC action co-funded by the Agence Nationale de la Recherche [ANR-17-HDIM-0001, DIME, https://anr.fr/Project-ANR-17-HDIM-0001]; and France 2030,
the French Government program managed by the French National Research Agency [ANR-16-CONV-0001, CENTURI, https://anr.fr/ProjetIA-16-CONV-0001]
and from Excellence Initiative of Aix-Marseille University - A*MIDEX [AMX-21-PEP-043].
Sébastien A. Choteau received funding from the “Espoirs de la recherche” program managed by the French Fondation pour la Recherche Médicale (FDT202106013072).